In RPE allografts, major histocompatibility complex II expression by the RPE (and its subsequent recognition by T cells; Zhang and Bok, 1998), along with cytokine production (interleukin [IL]-6 and interferon Î³) have been implicated in rejection (Enzmann et al., 2000).
